Table 3. Alteration of immunosuppression... | American Society of Hematology

Table 3.

Alteration of immunosuppression in patients achieving at least 25%reduction in liver function test values after 3 months of ECP

Patient no.	Liver function tests achieving 25% or greater reduction	Immunosuppressive medications			Change in immunosuppression
Patient no.	Liver function tests achieving 25% or greater reduction			CyA	Change in immunosuppression	MMF
2	γGT ALT	—	↔	Stable
3	γGT ALT AP	↔	—	Stable
7	γGT ALT AP B	—	↑	Increased
9	γGT ALT	↔	—	Stable
10	γGT ALT AP	↔	—	Stable
13	γGT	↔	—	Stable
20	γGT ALT	↔	—	Stable
27	γGT ALT AP	—	—	Stable

Patient no.	Liver function tests achieving 25% or greater reduction	Immunosuppressive medications			Change in immunosuppression
Patient no.	Liver function tests achieving 25% or greater reduction			CyA	Change in immunosuppression	MMF
2	γGT ALT	—	↔	Stable
3	γGT ALT AP	↔	—	Stable
7	γGT ALT AP B	—	↑	Increased
9	γGT ALT	↔	—	Stable
10	γGT ALT AP	↔	—	Stable
13	γGT	↔	—	Stable
20	γGT ALT	↔	—	Stable
27	γGT ALT AP	—	—	Stable

CyA indicates cyclosporin; —, not administered; ↔, dosage stable; AP, alkaline phosphatase; B, total bilirubin; and ↑, dosage increased.